145 related articles for article (PubMed ID: 20350780)
1. Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells.
Lee JH; Yoon JH; Yu SJ; Chung GE; Jung EU; Kim HY; Kim BH; Choi DH; Myung SJ; Kim YJ; Kim CY; Lee HS
Cancer Lett; 2010 Sep; 295(2):229-35. PubMed ID: 20350780
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells.
Jung EU; Yoon JH; Lee YJ; Lee JH; Kim BH; Yu SJ; Myung SJ; Kim YJ; Lee HS
Cancer Lett; 2010 Dec; 298(1):9-15. PubMed ID: 20573444
[TBL] [Abstract][Full Text] [Related]
3. Enhanced interleukin-2 diphtheria toxin conjugate-induced growth suppression in retinoic acid-treated hypoxic hepatocellular carcinoma cells.
Kim BH; Yoon JH; Myung SJ; Lee JH; Lee SH; Lee SM; Lee HS
Cancer Lett; 2009 Feb; 274(2):259-65. PubMed ID: 18986761
[TBL] [Abstract][Full Text] [Related]
4. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling.
Donato LJ; Noy N
Cancer Res; 2005 Sep; 65(18):8193-9. PubMed ID: 16166294
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding protein-II modulates RA mediated tumor cell proliferation and invasion.
Vo HP; Crowe DL
Anticancer Res; 1998; 18(1A):217-24. PubMed ID: 9568080
[TBL] [Abstract][Full Text] [Related]
6. Mammary carcinoma suppression by cellular retinoic acid binding protein-II.
Manor D; Shmidt EN; Budhu A; Flesken-Nikitin A; Zgola M; Page R; Nikitin AY; Noy N
Cancer Res; 2003 Aug; 63(15):4426-33. PubMed ID: 12907615
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
[TBL] [Abstract][Full Text] [Related]
8. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.
Miao J; Chen GG; Chun SY; Chak EC; Lai PB
Int J Oncol; 2004 Sep; 25(3):651-9. PubMed ID: 15289866
[TBL] [Abstract][Full Text] [Related]
9. Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells.
Kanki K; Akechi Y; Ueda C; Tsuchiya H; Shimizu H; Ishijima N; Toriguchi K; Hatano E; Endo K; Hirooka Y; Shiota G
J Hepatol; 2013 Nov; 59(5):1037-44. PubMed ID: 23831118
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
[TBL] [Abstract][Full Text] [Related]
11. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines.
Zou CP; Clifford JL; Xu XC; Sacks PG; Chambon P; Hong WK; Lotan R
Cancer Res; 1994 Oct; 54(20):5479-87. PubMed ID: 7522960
[TBL] [Abstract][Full Text] [Related]
12. Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells.
Stoner CM; Gudas LJ
Cancer Res; 1989 Mar; 49(6):1497-504. PubMed ID: 2538228
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation.
Carlisi D; Lauricella M; D'Anneo A; Emanuele S; Angileri L; Di Fazio P; Santulli A; Vento R; Tesoriere G
Eur J Cancer; 2009 Sep; 45(13):2425-38. PubMed ID: 19643600
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression.
Gwak GY; Yoon JH; Kim KM; Lee HS; Chung JW; Gores GJ
J Hepatol; 2005 Mar; 42(3):358-64. PubMed ID: 15710218
[TBL] [Abstract][Full Text] [Related]
15. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.
Tak E; Lee S; Lee J; Rashid MA; Kim YW; Park JH; Park WS; Shokat KM; Ha J; Kim SS
J Hepatol; 2011 Feb; 54(2):328-39. PubMed ID: 21056497
[TBL] [Abstract][Full Text] [Related]
16. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
17. CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation.
Blaese MA; Santo-Hoeltje L; Rodemann HP
Int J Radiat Biol; 2003 Dec; 79(12):981-91. PubMed ID: 14713576
[TBL] [Abstract][Full Text] [Related]
18. Competitive PCR demonstrates that 9-cis retinoic acid induces cellular retinoic acid-binding protein-II more efficiently than all-trans retinoic acid in human osteosarcoma cells.
Melhus H; Gobl A; Ljunghall S
Biochem Biophys Res Commun; 1994 Apr; 200(2):1125-9. PubMed ID: 8179592
[TBL] [Abstract][Full Text] [Related]
19. Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.
Lee J
Arch Pharm Res; 2010 Sep; 33(9):1401-9. PubMed ID: 20945139
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR
BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]